The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice

Anesthesiology

Volumn 99, Issue 4, 2003, Pages 876-881

  Homi, H Mayumi ^c   Yokoo, Noriko ^c   Ma, Daqing ^c   Warner, David S ^c   Franks, Nicholas P ^c   Maze, Mervyn ^a   Grocott, Hilary P ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITROGEN DIOXIDE; OXYGEN; XENON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; DRUG EFFECT; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ANIMALS; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; XENON;

EID: 0141655167     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200310000-00020     Document Type: Article

References (29)

1. Aziz TS: Xenon in anesthesia. Int Anesthesiol Clin 2001; 39:1-14
2. Dingley J, Ivanova-Stoilova TM, Grundler S, Wall T: Xenon: Recent developments. Anaesthesia 1999; 54:335-46
3. Kennedy RR, Stokes JW, Downing P: Anaesthesia and the 'inert' gases with special reference to xenon. Anaesth Intensive Care 1992; 20:66-70
4. Lynch C III, Baum J, Tenbrinck R: Xenon anesthesia. ANESTHESIOLOGY 2000; 92:865-8
5. Franks NP, Lieb WR: Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367:607-14
6. Yamakura T, Harris RA: Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels: Comparison with isoflurane and ethanol. ANESTHESIOLOGY 2000; 93:1095-101
7. de Sousa SL, Dickinson R, Lieb WR, Franks NP: Contrasting synaptic actions of the inhalational general anesthetics isoflurane and xenon. ANESTHESIOLOGY 2000; 92:1055-66
8. Franks NP, Dickinson R, de Sousa SL, Hall AC, Lieb WR: How does xenon produce anaesthesia? Nature 1998; 396:324
9. Wilhelm S, Ma D, Maze M, Franks NP: Effects of xenon on in vitro and in vivo models of neuronal injury. ANESTHESIOLOGY 2002; 96:1485-91
10. Sheng H, Bart RD, Oury TD, Pearlstein RD, Crapo JD, Warner DS: Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia. Neuroscience 1999; 88:185-91
11. Clark WM, Lessov NS, Dixon MP, Eckenstein F: Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol Res 1997; 19:641-8
12. Cullen S, Gross E: The anesthetic properties of xenon in animals and human beings, with additional observations on Krypton. Science 1951; 113: 580-2
13. Ma D, Yang H, Lynch J, Franks N, Maze M, Grocott H: Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. ANESTHESIOLOGY 2003; 98:690-9
14. Laskowitz DT, Sheng H, Bart RD, Joyner KA, Roses AD, Warner DS: Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia. J Cereb Blood Flow Metab 1997; 17:753-8
15. Sheng H, Brady TC, Pearlstein RD, Crapo JD, Warner DS: Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse. Neurosci Lett 1999; 267:13-6
16. Sheng H, Laskowitz DT, Bennett E, Schmechel DE, Bart RD, Saunders AM, Pearlstein RD, Roses AD, Warner DS: Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. J Cereb Blood Flow Metab 1998; 18:361-6
17. Garcia JH, Wagner S, Liu KF, Hu XJ: Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats: Statistical validation. Stroke 1995; 26:627-34
18. Cole DJ, Matsumura JS, Drummond JC, Schell RM: Focal cerebral ischemia in rats: Effects of induced hypertension, during reperfusion, on CBF. J Cereb Blood Flow Metab 1992; 12:64-9
19. Lam A, Winn H, Cullen B, Sundling N: Hyperglycemia and neurological outcome in patients with head injury. J Neurosurg 1991; 75:545-51
20. Li P-A, Shamloo M, Smith M-L, Katsura K-I, Siesjö BK: The influence of plasma glucose concentrations on ischemic brain damage is a threshold function. Neurosci Lett 1994; 177:63-5
21. Morikawa E, Mori H, Kiyama Y, Mishina M, Asano T, Kirino T: Attenuation of focal ischemic brain injury in mice deficient in the epsilon1 (NR2A) subunit of NMDA receptor. J Neurosci 1998; 18:9727-32
22. Mackensen GB, Patel M, Sheng H, Calvi CL, Batinic-Haberle I, Day BJ, Liang LP, Fridovich I, Crapo JD, Pearlstein RD, Warner DS: Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant. J Neurosci 2001; 21:4582-92
23. Memezawa H, Zhao Q, Smith ML, Siesjo BK: Hyperthermia nullifies the ameliorating effect of dizocilpine maleate (MK-801) in focal cerebral ischemia. Brain Res 1995; 670:48-52
24. Jevtovic-Todorovic V, Todorovic SM, Mennerick S, Powell S, Dikranian K, Benshoff N, Zorumski CF, Olney JW: Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med 1998; 4:460-3
25. Matsunaga T, Mukhin AG, London ED: Regionally distinct stoichiometry for N-methyl-D-aspartate receptor domains in brain. Neuroreport 1996; 7:833-7
26. Roth JE, Murray TF, Franklin PH: Regional distribution and characterization of [3H]dextrorphan binding sites in rat brain determined by quantitative autoradiography. J Pharmacol Exp Ther 1996; 277:1823-36
27. White PF, Way WL, Trevor AJ: Ketamine: Its pharmacology and therapeutic uses. ANESTHESIOLOGY 1982; 56:119-36
28. Yenari MA, Bell TE, Kotake AN, Powell M, Steinberg GK: Dose escalation safety and tolerance study of the competitive NMDA antagonist selfotel (CGS 19755) in neurosurgery patients. Clin Neuropharmacol 1998; 21:28-34
29. Goto T, Saito H, Shinkai M, Nakata Y, Ichinose F, Morita S: Xenon provides faster emergence from anesthesia than does nitrous oxide-sevoflurane or nitrous oxide-isoflurane. ANESTHESIOLOGY 1997; 86:1273-8